Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years - The Lancet Regional
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint | medRxiv
Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination | Microbiology Spectrum
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses - ScienceDirect
Boosting immunity to COVID-19 vaccines | Nature Medicine
Boosting immunity to Omicron | Nature Medicine
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Vaccines | Free Full-Text | mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study in: The American Journal of Tropical ...
COVID-19 vaccine booster dose benefits patients with cancer
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases
Antibody titers in turkeys increase after multiple booster vaccinations with an attenuated Salmonella live vaccine | BMC Research Notes | Full Text
Prof. Akiko Iwasaki on X: "Why do we need a booster shots? This is because B cell responses induced by first dose only generates lower levels, lower affinity and short lived antibody
COVID-19 antibodies appear to wane rapidly, so prepare for booster shots, study suggests – Orange County Register
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222 - ScienceDirect
Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron
Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
